Related by context. All words. (Click for frequent words.) 62 See CLINICAL PHARMACOLOGY 62 Analytical Method 62 Clinical Trial Data 61 Clinical Practice Guidelines 61 Bipolar Disorders 61 Refractory Angina 61 Clinical Practice Guideline 61 Late Breaker 61 Preterm Labor 61 Pandemic Influenza Vaccines 61 Immune Mediated 61 ASCO Breast Cancer 61 RNAi Therapeutic 60 Biological Therapy 60 Rhinosinusitis 60 Biochemical Pharmacology 60 Autoimmune Diseases 60 Cancer Vaccines 60 Chemoprevention 60 Aggressive Reduction 60 Intervention Trial GAIT 60 NAEPP 60 Tumor Response 59 ANN INTERN MED 59 Diagnostic Criteria 59 Antibody Therapeutics 59 Autoimmune Disease 59 Gastric Cancer 59 Pediatric Asthma 59 Inflammatory Bowel Diseases 59 Treating Chronic 59 Neoplasia 59 Preliminary Findings 59 Randomized Controlled Trials 59 Rotavirus Vaccine 59 Vaccine Protects Against 59 Prolongs Survival 59 Consensus Statement 59 ASM Biodefense 59 Surgical Treatment 59 Pregnancy Outcomes 59 Inflammatory Arthritis 59 Therapeutic Approaches 59 Clinical Guideline 59 Severe Asthma 59 Hepatocellular Carcinoma 59 Improve Diagnosis 58 Novel Treatments 58 Patient Outcomes 58 Coronary Revascularization 58 Meta Analysis 58 Cognitive Impairment 58 Protein Involved 58 Early Diagnosis 58 Overactive Bladder 58 rPA Anthrax Vaccine 58 Smooth Muscle 58 Novel Therapies 58 Schizophrenia Treatment 58 Differential Diagnosis 58 Inflammatory Markers 58 Clinical Efficacy 58 Molecular Cancer 58 Mesothelioma Treatment 58 Arterial Hypertension 58 Pooled Analysis 58 Innate Immunity 58 Laryngeal Cancer 58 Dendritic Cells 58 Investigational Treatment 58 Renal Function 58 Minimally Invasive Treatment 58 Myeloproliferative Disorders 58 Tuberculosis Vaccine 58 Vascular Targeting Agents 58 Uterine Cancer 58 Advanced Renal Cell 58 Novel Mechanism 58 Solid Tumors 58 Detection Evaluation 58 Investigational Drugs 58 Practice Guideline 58 Medication Adherence 58 Demonstrates Efficacy 58 Metabolic Disorder 58 Contraindications 58 Arch Dermatol 58 #:#-# [033] 58 Randomized Double blind 58 Clinical Outcome 58 Diabetic Foot Ulcer 58 Lung Injury 57 Oral Abstract 57 SCAI Annual 57 Acute Treatment 57 Colorectal Screening 57 AAEP Convention 57 Arch Surg 57 Bioequivalence 57 Innovative Approaches 57 Gynecologic Cancers 57 Arch Neurol 57 Prospective Multicenter 57 Glycation 57 Clinical Evaluation 57 #th Annual Interscience 57 Oral Mucositis 57 Aromatase Inhibitors 57 Am J Epidemiol 57 Glucosamine Chondroitin Arthritis 57 Chronic Heart Failure 57 Diagnosis Treatment 57 Severe Sepsis 57 Vaccine Immunology 57 Chronic Liver Disease 57 Molecular Mechanisms 57 Progenitor Cells 57 Vitamin D Deficiency 57 Pemphigus 57 Menopausal Symptoms 57 ICAAC IDSA 57 HCV Protease Inhibitor 57 Female Urology 57 Prognostic Factors 57 Biological Effects 57 Stereotactic Radiosurgery 57 Molecular Diagnostic 57 Patient Oriented 57 Hematological Cancers 57 Iron Deficiency Anemia 57 Thyroid Hormone 57 Coronary Angiography 57 OARSI 57 Stakeholder Workshop 57 Multidisciplinary Approach 57 Seasonal Influenza Vaccine 57 Thromboembolic 57 Myoblast 57 Neurodegenerative 57 Therapeutic Strategies 57 Hematologic Malignancies 57 Hematopoietic Stem Cell Transplantation 57 Diabetic Neuropathy 57 Clinical Trial Results 57 Venous Thromboembolism 57 Systemic Sclerosis 57 Tyrosine Kinase Inhibitor 57 Antibacterial Drug 57 Pharmacoepidemiology 57 FDA Anti Infective 57 Childhood Asthma 57 Chronic Lyme Disease 57 Relapsing Multiple Sclerosis 57 Low Dose 57 Limb Salvage 57 Therapeutics Roundtable 57 Process Validation 57 Nerve Regeneration 57 Diastolic Heart Failure 57 MRSA Infections 57 Ischaemic 57 Evaluation WISE 57 Vulnerable Plaque 57 Respiratory Virus 56 HDAC Inhibitor 56 EFNS 56 Ophthalmic Drug 56 Muscle Wasting 56 Toxicity Testing 56 Pafuramidine 56 journal Arteriosclerosis Thrombosis 56 Breast Carcinoma 56 Issues Surrounding 56 Gynecological Cancer 56 Endocrine Practice 56 Pharmacologic 56 Placebo Controlled Study 56 Arch Intern Med 56 Eur Urol 56 Arch Pediatr Adolesc Med 56 Therapeutic Potential 56 Knee Osteoarthritis 56 NCCN Drugs 56 Respiratory Infections 56 Double Blind Placebo 56 JAK Inhibitor 56 Reproductive Toxicology 56 Carotid Stenting 56 Prostate Disease 56 Outpatient Setting 56 Cognitive Function 56 Fungal Infections 56 Canaccord Adams Hepatitis C 56 Molecular Medicine Tri 56 Renal Cancer 56 Antiplatelet 56 Hematological 56 Molecular Pathogenesis 56 Systematic Review 56 Diabetic Kidney Disease 56 MEDCAC 56 LSRO 56 Multiple Myeloma Patients 56 Metabolic Endocrinology 56 Anti Inflammatory Drug 56 Investigational Drug 56 J Pediatr 56 Uterine Fibroid 56 Immunogenicity 56 Biomarker Study 56 Antiepileptic Drugs 56 Environ Health Perspect 56 Lymphocytic 56 Myelodysplastic Syndromes 56 Sangamo BioSciences Announces 56 Human Gene Therapy 56 Epilepsy Surgery 56 Prospective Randomized 56 Liprotamase 56 Sleep Disturbances 56 Preterm Birth 56 Breaking Clinical Trials 56 Prostate Cancer Survival 56 ASCO GI 56 Shows Efficacy 56 Stent Placement 56 Muscle Function 56 Gynecol Oncol 56 Cardiovascular Disease Risk 56 Secondary Hyperparathyroidism 56 First Patient Enrolled 56 Ann Emerg Med 56 Skeletal Muscle 56 BMC Musculoskeletal Disorders 56 Adjuvant Chemotherapy 56 Diagnostic Tests 56 Acute Stroke 56 Cognitive Deficits 56 Alternative Approaches 56 Tumor Progression 56 ASGCT 56 Experimental Vaccine 56 Immunomedics Announces 56 Gastrointestinal Disorders 56 Treating Depression 55 Radiation Induced 55 Therapeutic Targets 55 Phase Ib Clinical Trial 55 Endovascular Therapy 55 Women Ischemia Syndrome 55 Neuroendocrine Tumor 55 Shows Promise Against 55 AA Amyloidosis 55 Cancer Immunotherapy 55 Antiviral Drugs 55 Vector Borne 55 Governmental Industrial Hygienists 55 Oral Fingolimod 55 Regulatory Toxicology 55 Pulmonary Arterial Hypertension 55 Hormone Refractory Prostate Cancer 55 Nutritional Status 55 Dose Response 55 Demonstrates Sustained 55 Childhood Vaccinations 55 Aethlon Medical Announces 55 Comparative Effectiveness 55 Intravenous Formulation 55 Cardiotoxicity 55 Neurotoxicity 55 Chronic Obstructive Lung 55 Immunologic 55 Cardiovascular Interventions 55 Risk Behavior 55 Genitourinary Cancer 55 Colorectal Cancer Screening 55 Decitabine 55 Neuropathic Pain 55 Rheumatoid Arthritis Patients 55 Potent Antiviral Activity 55 Combination Treatment 55 Related Cancers 55 Analytical Methods 55 Quadrivalent 55 Genetic Variation 55 Fifth Decennial International 55 Reduces Mortality 55 Podium Presentation 55 Etiology 55 Long Term Efficacy 55 Diabetic Macular Edema 55 #:#-# [037] 55 Oral Cavity 55 Lumbar Spine 55 Phase 2b Study 55 Arthritis Musculoskeletal 55 Diabet Med 55 Progressive Multifocal Leukoencephalopathy 55 Viral Disease 55 Glycobiology 55 Breast Density 55 Issues Relating 55 Asthma Intervention 55 Genetic Screening 55 Dose Escalation 55 Mimetics 55 Osteoarthritis Patients 55 Novel Antibiotic 55 Lactose Intolerance 55 Growth Hormone Deficiency 55 Hepatitis C Infection 55 Sipuleucel T 55 Drug Resistant Tuberculosis 55 Periodontal Disease 55 Rheumatoid 55 STRIDE PD 55 Metabolic Disease 55 Nicotine Vaccine 55 Obes Res 55 ASBMR 55 Antitumor 55 Peri Operative 55 Fondaparinux 55 Antimicrobial Resistance 55 Eur J Cancer 55 Novel Therapeutic 55 Diabetes Digestive 55 #:# -# [003] 55 Serious Adverse Events 55 Cytometry 55 Improving Patient Safety 55 Program NCEP 55 Risk Stratification 55 Levels Linked 55 Subgroup Analysis 55 Allergies NDA 55 Solid Tumor 55 #:#-#,# CrossRef Medline [002] 55 Biobehavioral 55 Patient Registry 55 Cancer Incidence Mortality 55 Telik Announces 55 BCIRG 55 Molecular Basis 55 J Clin 55 Showed Significant 55 MEK Inhibitor 55 rhLF 55 Study Evaluating 55 Psychiatric Diagnosis 55 Chronic Lymphocytic Leukemia 55 enzyme immunoassay EIA 55 Therapeutic Arthritis 55 Orthostatic Hypotension 55 Unapproved Drugs 55 Tumor Markers 55 Prenatal Diagnosis 55 Hypertriglyceridemia 54 Preterm Delivery 54 Diabetes Complications 54 Antiviral Therapy 54 Reproducibility 54 Therapeutic Advances 54 Anticancer Drugs 54 Continence Society 54 Double Blind Randomized 54 WCDR 54 Calcium Vitamin D 54 Adverse Effects 54 Hematologic 54 Cervical Dysplasia 54 Anticoagulation 54 Aurora Kinase 54 Intensive Care Medicine 54 Systemic Therapy 54 number NCT# ClinicalTrials.gov 54 Therapeutic Efficacy 54 Cardiovascular Outcomes 54 Fat Grafting 54 Advanced Melanoma 54 Microalbuminuria 54 Contact Dermatitis 54 Bone Metabolism 54 BioSante Pharmaceuticals Reports 54 Disruptive Behavior 54 Limb Preservation 54 Golimumab 54 Neurologic Disorders 54 Thrombotic 54 Lung Cancer Screening 54 Lower Extremity 54 Multicenter Trial 54 Hypercholesterolemia 54 Drug Prevents 54 Predictive Toxicology 54 Kidney Transplant Patients 54 J Natl Cancer Inst 54 Hospital Acquired Pneumonia 54 Rotavirus Vaccines 54 Bloodstream Infections 54 SABCS 54 Chronic Wounds 54 Novel Vaccine 54 Peer Reviewed Journal 54 Statin Drugs 54 Truvada tablets 54 Allergic Rhinitis 54 Repligen Announces 54 Clinical Decision Making 54 Pediatric Diabetes 54 Therapeutics TCT scientific 54 Viral Infections 54 Silicone Breast Implant 54 Motility 54 Placebo Controlled Trial 54 Guideline Update 54 Human Neural Stem 54 Clinical Outcomes 54 Am J Clin 54 Treating Prostate Cancer 54 USP Verification 54 Improves Outcomes 54 Migraine Headache 54 Preclinical Efficacy 54 Malignant Glioma 54 Adverse Event 54 Maven Semantic 54 Pirfenidone 54 Acute Pain 54 Oral Fluid 54 Lung Cancer Drug 54 Acute Ischemic Stroke 54 Inhaled Nitric Oxide 54 Selective Cardiac Myosin Activator 54 Hepatotoxicity 54 Septic Shock 54 Valopicitabine 54 Diabetic Nephropathy 54 Catheterization 54 Pressure Ulcers 54 Crit Rev 54 Dietary Reference Intakes 54 Ischemic 54 Protease Inhibitors 54 Test Detects 54 Thromboembolism 54 Conducting Clinical Trials 54 Hematological Malignancies 54 Cancer Biomarkers 54 Kidney Disease Education 54 AACR San Antonio 54 Malaria Vaccine 54 Orphan Diseases 54 J Nutr 54 Bone Metastases 54 Sustained Efficacy 54 Substance Dependence 54 Pharmacogenetic 54 Spine Patient Outcomes 54 ECCMID 54 Mortality Risk 54 Paediatric Gastroenterology 54 Clin Trials 54 Package Insert 54 Prostate Cancer Treatment 54 Antiepileptic Drug 54 Chicago Multidisciplinary Symposium 54 Postmenopausal Women 54 Cerebrovascular Diseases 54 Effectively Treats 54 Oral Calcitonin 54 Clinical Toxicology 54 Percutaneous Tibial Nerve Stimulation 54 Investigator Initiated 54 Human Retroviruses 54 Expert Advisory Panel 54 Pandemic Influenza Preparedness 54 Vaccine Trials 54 Autologous Stem Cell Transplantation 54 Thromb Haemost 54 Trigeminal Neuralgia 54 Adjuvant Treatment 54 Postdoctoral Position 54 #:#-# [031] 54 Foodborne Illness 54 Multidrug Resistant 54 Ovarian Cancers 54 J Am Coll 54 Novel Small Molecule 54 Psychodynamic Psychotherapy 54 Endothelial Function 54 Phase 2a Trial 54 Neuroprotective Effects 54 Evidenced Based 54 Prognostic Significance 54 Interferon Alfa 54 Anti Angiogenesis 54 Psychosocial Aspects 54 Artificial Organs 54 Helicobacter Pylori 54 Prostate Screening 54 Phase III Clinical Trials 54 Hepatitis C Treatment 54 Anti Infective 54 Diabetologia 54 Antiplatelet Therapy 54 Nymox NX 54 Cardiovascular Risk Reduction 54 Socioeconomic Status 54 BizAcumen LLC 54 Demonstrate Significant 54 Cellular Tissue 54 Postmarketing 54 Study Shows Benefits 54 Randomized Clinical Trials 54 Immune Cell 54 Perinatology 54 Interstitial Cystitis 54 Cytogenetic 54 Glucosamine chondroitin Arthritis 54 Prenatal Screening 54 #-# Full Text 54 Investigational Agent 53 Dermatologic 53 Ophthalmic Drugs Advisory 53 Catheter Associated 53 Functional Outcomes 53 Spinal Manipulation 53 Generalized Anxiety Disorder 53 Chronic Lung 53 Novel Inhibitor 53 Upcoming Investor 53 Interferon Beta 53 Docosahexaenoic Acid 53 Beneficial Effects 53 Carotid Endarterectomy 53 Liver Disease 53 Neurodegenerative Disease 53 Postmarket 53 Racial Ethnic Disparities 53 Controlled Study 53 #:#-#,# [002] 53 Neuroepidemiology 53 Antibiotic Use 53 Patellofemoral 53 Nonalcoholic Fatty Liver Disease 53 NCCTG N# 53 Nuvelo Announces 53 Toxicogenomics 53 Combo Therapy 53 Pelvic Pain 53 Chronic Kidney 53 Protein Therapeutics 53 S#.# [006] 53 Sevelamer 53 Neonatal Medicine 53 Ophthalmic Surgery 53 Brain Function 53 Febrile Neutropenia 53 Neurological Devices 53 CALERIE 53 Anti Infective Drugs 53 entitled Formulary Advantages 53 Hazardous Drugs 53 #:# -# [004] 53 RhuDex 53 Lung Transplantation 53 Guidance Document 53 Pediatric Rheumatology 53 #:#-#,# [003] 53 Estrogen Receptor 53 Protein Interaction 53 Cannabinoid 53 Randomized Controlled 53 Pharmacotherapy 53 J Neurosurg 53 Pandemic Flu Preparedness 53 Dietary Fat 53 H pylori infection 53 Am J Pathol 53 Iron Overload 53 LibiGel ® 53 Oral Formulation 53 Controlled Trial 53 Novel Oral 53 Pharmacodynamics 53 Kidney Disease Outcomes 53 Phase 2b Clinical Trial 53 Liver Fibrosis 53 Stent Thrombosis 53 Depressive Symptoms 53 Organic Synthesis 53 Neurotherapeutics 53 Dietetic Products 53 doi Abstract Free 53 Female Sexual Arousal 53 Slow Progression 53 Orthomolecular 53 Brain Stimulation 53 Guidelines Issued 53 Talabostat 53 Oral Anticoagulants 53 Dupuytren Contracture 53 Minimally Invasive Surgical 53 Practical Aspects 53 Pluripotent Stem Cells 53 Cervical Spine 53 Subtypes 53 Arrhythmias 53 undergoing Percutaneous Coronary 53 Clinical Trials Update 53 Demonstrates Potent 53 Pemphigus Vulgaris 53 Drug Candidate 53 Lipid Lowering Treatment 53 Treatment Resistant 53 Peptic Ulcer 53 Perinatal Mortality 53 Systematic Reviews 53 Randomized Double Blind 53 Kuvan sapropterin dihydrochloride 53 Ocular Surface 53 oral dual endothelin 53 Schizophrenia Bulletin 53 Molecular Mechanism 53 Pediatric Inflammatory Bowel Disease 53 Platelet Function 53 Psychological Stress 53 Antiviral Activity 53 Pneumococcal Disease 53 Pre Exposure Prophylaxis 53 Two Upcoming Investor 53 article #.#/NEJMoa# 53 Cervical Cytology 53 Human Embryo 53 Clostridium difficile Associated 53 Bipolar Mania 53 Coronary Disease 53 Hedgehog Pathway 53 Coronary Artery Bypass Graft 53 Drug Shows Promise 53 Insulin Glargine 53 Dialysis Outcomes 53 NCCN Updates 53 Bronchopulmonary Dysplasia 53 Renal Cell Carcinoma 53 Dual Antiplatelet Therapy 53 Main Outcome Measure 53 Statistically Significant 53 Left Ventricular Dysfunction 53 Cardiovascular Imaging 53 QLT# 53 #:#-# [019] 53 Decompensated Heart Failure 53 Oral Insulin 53 Radiofrequency Ablation 53 RNA Therapeutics 53 Causes Symptoms 53 Suicidality 53 Diagnostic Assay 53 doi #.# 53 Ann Oncol 53 Renal Disease 53 BARI 2D 53 Islet Transplantation 53 Fixed Dose 53 Patient Focused 53 Pharmacokinetic Study 53 Eye Diseases 53 Racial Disparities 53 PLoS Neglected Tropical Diseases 53 ACCF AHA 53 XPEL Announces 53 Neurological Disorder 53 Pathogen Detection 53 Fabry Disease 53 Chronic Renal Failure 53 Voluntary Consensus 53 Colon Cleansing 53 WEB OF SCIENCE 53 Anticoagulant 53 PROactive 53 Human Reproduction CERHR 53 BENECOL R Spreads 53 Muraglitazar 53 Mycophenolate Mofetil 53 Antidepressant Treatment 53 Pressure Ulcer 53 Biodetection Technologies 53 Antihypertensive 53 Safinamide 53 Intracerebral Hemorrhage 53 Oncologic Drugs Advisory 53 Child Mortality 53 Cochrane Database Syst Rev 53 Hydroxyurea 52 Coronary Artery Calcium 52 Breast Cancer Recurrence 52 #:#-# [007] 52 Heart Failure Patients 52 BEXXAR Therapeutic Regimen 52 Bare Metal Stent 52 Topics Covered Executive 52 Free Full Text 52 Improving Outcomes 52 Lung Cancer WCLC 52 Cardiovascular Metabolic 52 Hemostasis 52 H#N# Influenza Vaccine 52 Observational Studies 52 Carcinogenesis 52 Pediatric Cardiac 52 Cholesterol Levels SPARCL 52 Bioassays 52 journal Antimicrobial Agents 52 Cell Signalling 52 AASLD 52 Prophylactic Treatment 52 Bronchiectasis 52 Personality Disorders 52 Melanoma Skin Cancer 52 Newborn Hearing Screening 52 Pioglitazone 52 IOVS 52 Moxifloxacin 52 Warfarin Coumadin 52 Surgical Pathology 52 Left Ventricular 52 Teva Provides Update 52 FDA Approves Drug 52 Newly Diagnosed Multiple Myeloma 52 Cardiovascular Risk 52 Acute Myocardial Infarction 52 Neuroendocrine Tumors 52 Screening Mammography 52 Early Lung Cancer 52 Alexco Announces 52 Antiviral Drug 52 Neurotology 52 Pelvic Floor 52 www.nejm.org 52 #th Interscience Conference 52 FDA Critical Path 52 Hormonal Therapy 52 Ranolazine 52 Am J Geriatr 52 Psychiatric Illness 52 Cardiac Rhythm 52 American Migraine Prevalence 52 Cardiac Transplantation 52 AIDS Vaccine 52 Newborn Screening 52 Myocardial Ischemia 52 immunomodulatory agents 52 JACC Cardiovascular Interventions 52 Weight Loss Supplement 52 Airway Inflammation 52 Tolvaptan 52 Acute Kidney 52 Peer Reviewed Medical 52 Authorized Generics 52 Erythropoietic 52 Pivotal Phase III 52 Vaccine Diphtheria CRM# Protein 52 Urologic Nursing 52 Neurosurgery Spine 52 Metabolic Disorders 52 Results Release Date 52 Analytical Tool 52 Outcome Measures 52 Peripheral Arterial 52 Foreclosure Mitigation 52 Expert Consensus 52 Sentinel Lymph Node 52 Elagolix 52 Preventing Medication Errors 52 Final Appraisal Determination 52 Neural Therapy 52 Phase III Clinical Trial 52 Intervention Effectiveness CATIE 52 Belimumab 52 Practical Applications 52 Neurochemistry 52 Healing Wounds 52 Thiazolidinediones 52 Pervasive Developmental Disorders 52 Breast Cancer Stem Cells 52 Tigecycline 52 Investigational Compound 52 HCV SPRINT 52 FDA Oncologic Drugs 52 Meets Primary Endpoint 52 Nonsurgical 52 Valvular 52 #:#-# Abstract Free [004] 52 Premature Birth 52 Geriatric Cognitive Disorders 52 Endoluminal 52 Natalizumab 52 Clin Chem 52 Mortality Weekly 52 Patients Receiving 52 TORISEL TM 52 Confirms Efficacy 52 Ovarian PLCO Cancer 52 Idiopathic Pulmonary Fibrosis 52 A/#/# [002] 52 Stroke Prevention 52 EFSA Panel 52 Clinical Neuropsychology 52 RE MODEL 52 Test Methodology 52 Acne Drug 52 Nuclear Receptors 52 HDL Selective Delipidation 52 Interpersonal Violence 52 Anticancer Agents 52 Bazedoxifene 52 AOSSM 52 Pharmacoeconomic 52 Breast Ovarian Cancer 52 Arthritis Drugs 52 Recurrent Prostate Cancer 52 TB Vaccine 52 Pharmacoeconomics 52 Devices Advisory Panel 52 Phase 1b Clinical Trial 52 Resurgex Plus 52 ISPOR 52 Pediatric Neurological Surgery 52 Intervention Trial 52 Nutrition Physical Activity 52 Carbidopa Levodopa 52 ASSERT 52 Pharmacodynamic 52 Cinacalcet 52 Suppl. 52 Allograft 52 www.pranabio.com 52 Schiavo Autopsy 52 Hepatitis Virus 52 Musculo Skeletal Disorders 52 Kinase Inhibitor 52 Pandemic Influenza Vaccine 52 Recombinant DNA 52 Sustained Release 52 Cardiac Stem Cell 52 dual endothelin receptor antagonist 52 First Patient Dosed 52 Patients Treated With 52 Curr Opin 52 Quality Indicators 52 Cytotoxicity 52 NCI Cancer 52 ALN HPN 52 Dr. Gulfo 52 Platelet Inhibition 52 congenital toxoplasmosis 52 Currency Majors Technical 52 Aortic Dissection 52 Targeted Anticancer Therapies 52 Gastrointestinal Oncology 52 Resistant Hypertension 52 Ocrelizumab 52 Combination REOLYSIN R 52 Treatment Shows Promise 52 Upward Revision 52 Postmenopausal Hormone Therapy 52 Chagas Disease 52 assn.org 52 Genetic Counseling 52 Lancet Oncology journal 52 Aortic Stenosis 52 Neuroprotection 52 Allergies Asthma 52 #:#-# [035] 52 Pathological Gambling 52 Psychiatric Services #:#-#,# 52 Clinical Oncology Gastrointestinal Cancers 52 Benign Prostatic Hyperplasia 52 Mg Usa 52 Childhood Immunization 52 Improved Outcomes 52 Therapy Reduces 52 Pharmacy OneSource Announces 52 Prevent Obesity 52 Sapacitabine 52 Bioavailability 51 Prevalence Worldwide 51 Biologics Compendium 51 Developmental Therapeutics 51 Clinical Therapeutics 51 Candesartan 51 Diverse Populations 51 Nosocomial 51 Gynecologic Cancer 51 User Requirements 51 Therapeutic Intervention 51 See WARNINGS 51 EuroIntervention 51 #:#-# [029] 51 Metabolic Drugs 51 Observational Study 51 Teratology 51 www.ecri.org 51 BARDA Industry 51 #:#-# Abstract Free [010] 51 CTRC AACR San Antonio 51 CHAMPION PCI 51 Biomedical Optics 51 Renal Failure 51 HPV Vaccination 51 guanfacine extended release 51 Fibroid 51 prospective observational studies 51 Multicenter Phase 51 Randomized Phase 51 Minimally Invasive Spine Surgery 51 Neural Stem Cells 51 Genetically Engineered Animals 51 Nephrol Dial Transplant 51 Eculizumab 51 Cervical Cancer Prevention 51 prospective multicentre 51 Demonstrates Significant 51 Percutaneous Coronary Interventions 51 MANAGEMENT DISCUSSION AND ANALYSIS 51 Nebulized Formoterol 51 ONTARGET 51 Echocardiographic 51 AICR WCRF 51 Foodborne Pathogens 51 Western Airborne Contaminants 51 Chronic Diseases 51 Blood Pressure Measurement 51 Acute Decompensated Heart Failure 51 Carotid Revascularization Endarterectomy vs. 51 ASCO Prostate Cancer 51 Cervical Pathology 51 Childhood Diseases 51 Nicotine Addiction 51 Beta Blocker 51 Neural Repair 51 Nesiritide 51 Climatic Changes 51 Pediatric Bipolar Disorder 51 Blood Pressure Monitoring 51 Cancer Incidence 51 Treated Patients 51 Renal Transplantation 51 Percutaneous Coronary Intervention 51 Cholesterol Lowering Drug 51 ACR ARHP 51 NOXAFIL 51 Abortion Breast Cancer 51 Aflibercept 51 Total Knee Arthroplasty 51 Patients Undergoing 51 Bucindolol 51 Denufosol 51 Dose Ranging Study 51 Ozarelix 51 ARBITER 6 51 Randomized Double Blind Placebo 51 Prostate AdenoCarcinoma Treatment 51 scientific journal PNAS 51 Content Outline 51 Physical Exams 51 Avian Flu Vaccine 51 Diabetes Endocrinology 51 EORTC NCI 51 NOMID 51 Iodine Deficiency 51 Antimicrobials 51 Pediatric Imaging 51 Effective Treatments 51 Interoperability Standards 51 NESARC 51 GASB Issues 51 Neuropsychologia 51 Better Outcomes 51 Bioeffects 51 Zoonotic 51 FDA Advisory Panel 51 AHRQ Evidence 51 #:#-# Abstract Free [009] 51 Viral Hepatitis 51 Menstrual Cycle 51 Diabetes Epidemic 51 Reperfusion Injury 51 Etanercept 51 IL# PE#QQR 51 Proteasome 51 J Am Acad 51 Stop Hypertension DASH 51 CABG Surgery 51 Issues Shareholder 51 Biosurveillance 51 Endovascular Therapy ISET